Walter V. Klemp, CEO and President at Moleculin Biotech, Inc. (MBRX), bought 195,168 shares at $0.97 ($191K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.97 | 85,213 | $83K | 43.4% |
| 2 | $0.97 | 85,213 | $83K | 43.4% |
| 3 | $1.02 | 24,742 | $25K | 13.2% |
| Total | $0.98 avg | 195,168 | $191K | 100% |
| Filing → |
| MBRX | BUY | 2022-11-28 | $58K | — | Filing → |
| MBRX | BUY | 2022-11-23 | $26K | — | Filing → |
| MBRX | SELL | 2017-08-18 | $170K | — | Filing → |